Medical data and technology company HeraMED (ASX: HMD) has achieved record user growth for pregnant mothers currently using its innovative HeraCARE platform.
Record User Growth
In excess of 3,800 expectant mothers, as at 30 September 2024, have now been onboarded onto the HeraCARE platform and continues to demonstrate the growing adoption of the digital maternity care solution. Pleasingly the number of active users continues to reach new records also with in excess of 710 mothers currently having their pregnancies managed through the HeraCARE platform. This increase in user growth is continuing to build our evidence base and value proposition that HeraCARE is improving the existing standard of care in pregnancy.
Successful Hospital Implementation in Florida
The primary driver behind the current increase in user numbers has been the incredibly successful launch of HeraCARE at Broward Health in Florida. Since going live 207 pregnant mothers have been successfully onboarded in the first 100 days.
Over the first 100 days significant enhancements to HeraCARE have been undertaken in defining care plans to better support patients with specific conditions including chronic hypertension, gestational diabetes, mental health both for antenatal and postpartum, financial hardship as well as low risk pregnancies. Nine customised care plans now form the backbone of how customised care is being provided and managed through the use of HeraCARE.
With care models and workflows now defined the intention is to begin to support a scaling of mothers on HeraCARE with Broward.
Pleasingly, HeraCARE continues to lead to a number of time-critical interventions for prenatal and postpartum mothers and has already impacted care and delivery protocols, leading to better outcomes across our various sites.
This rapid adoption in a clinical setting highlights the HeraCARE’s ability to seamlessly integrate into existing healthcare systems and provide valuable support to both patients and healthcare providers.
“It’s incredibly exciting to collaborate with customers that share an aligned vision to change maternity and pregnancy care outcomes. A key pillar in our strategic plans was to be customer first and ensure HeraCARE is ‘fit for purpose’,” Managing Director and CEO, Anoushka Gungadin, said.
“Our platform enhancements have focused on workflow refinement, smart notification configuration, chat and telehealth implementation, care plan design, and notifications for complex care populations, and to see our user growth be underpinned by this customer focus is very rewarding.
“We have further interest from other Florida based health systems based on our success at Broward who we are engaging with. We are at the start of our commercialisation journey and our pipelines continue to expand and our evidence base continues to grow. I look forward to updating shareholders on further customer success in the coming weeks.”
